QT
DOVA

Quantbot Technologies’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Quantbot Technologies’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,989
Closed -$89K – 1678
2018
Q2 		$89K Buy
+2,989
New +$81.4K 0.01% 895

Other funds holding DOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Quantbot Technologies's DOVA Position: Q3 2018 in Review

Quantbot Technologies sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2018, closing a stake of 2,989 shares — an estimated $89K sold.

Quantbot Technologies first reported a position in DOVA in Q2 2018 and held it in 1 quarter. The position peaked at $89K in Q2 2018. 63 funds tracked by Wall St. Rank hold DOVA as of Q3 2018.

  • Quantbot Technologies reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Quantbot Technologies sold 2,989 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $89K.
  • Quantbot Technologies first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Quantbot Technologies's Dova Pharmaceuticals, Inc. Common Stock position peaked at $89K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Quantbot Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.